Pinealon
Pinealon is a synthetic tripeptide with the amino acid sequence Glu-Asp-Arg (EDR), developed within the Khavinson short-peptide bioregulator research framework. It has been investigated in preclinical research for its potential neuroprotection-related, oxidative-stress, gene-expression, and cellular signalling activity within nervous system biology.
Pinealon
Sale!
Pinealon is a synthetic tripeptide with the amino acid sequence Glu-Asp-Arg (EDR), developed within the Khavinson short-peptide bioregulator research framework. It has been investigated in preclinical research for its potential neuroprotection-related, oxidative-stress, gene-expression, and cellular signalling activity within nervous system biology.
$165.00
Buy more, save more!
-
Save 2%
Buy 3, get $2.50 off each
$165.00Per item: $162.50Total price: $487.50 -
Save 2%
Buy 5, get $3.75 off each
$165.00Per item: $161.25Total price: $806.25 -
Save 5%
Buy 10, get $7.50 off each
$165.00Per item: $157.50Total price: $1,575.00
$175.00$165.00
99+% PURITY
All peptides are third-party lab tested.
SECURE PAYMENT
Your payments are secure with our private security network.
FREE SHIPPING
for orders over $250
Description
Additional information
Reviews (0)
In preclinical research, Pinealon has been investigated for its potential effects on neuronal survival, cellular responses to oxidative stress, and molecular mechanisms involved in nervous system biology. Proposed mechanisms suggest that short bioregulatory peptides may influence gene expression through interactions with chromatin and other regulatory pathways. However, these mechanisms remain under investigation and have not been conclusively established.
Current areas of preclinical research include:
- Investigated in experimental models of age-related neurological changes to better understand its potential effects on neuronal function and cellular regulation during aging.
- Influence on gene expression and other peptide-mediated regulatory processes in neural cells, although these proposed mechanisms require further validation.
Pinealon is a member of a family of short bioregulatory peptides developed through the research program led by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology.
There are no reviews yet.